Abstract:Background: Lead exposure is a risk factor for cardiovascular disease mortality, but the number of deaths in the USA attributable to lead exposure is poorly defined. We aimed to quantify the relative contribution of environmental lead exposure to all-cause mortality, cardiovascular disease mortality, and ischaemic heart disease mortality. Methods: Our study population comprised a nationally representative sample of adults aged 20 years or older who were enrolled in the Third National Health and Nutrition Examination Survey (NHANES-III) between 1988 and 1994 and followed up to Dec 31, 2011. Participants had completed a medical examination and home interview and had results for concentrations of lead in blood, cadmium in urine, and other relevant covariates. Individuals were linked with the National Death Index. This study presents extended follow-up of an earlier analysis. Findings: We included 14 289 adults in our study. The geometric mean concentration of lead in blood was 2·71 μg/dL (geometric SE 1·31). 3632 (20%) participants had a concentration of lead in blood of at least 5 μg/dL (≥0·24 μmol/L). During median follow-up of 19·3 years (IQR 17·6-21·0), 4422 people died, 1801 (38%) from cardiovascular disease and 988 (22%) from ischaemic heart disease. An increase in the concentration of lead in blood from 1·0 μg/dL to 6·7 μg/dL (0·048 μmol/L to 0·324 μmol/L), which represents the tenth to 90th percentiles, was associated with all-cause mortality (hazard ratio 1·37, 95% CI 1·17-1·60), cardiovascular disease mortality (1·70, 1·30-2·22), and ischaemic heart disease mortality (2·08, 1·52-2·85). The population attributable fraction of the concentration of lead in blood for all-cause mortality was 18·0% (95% CI 10·9-26·1), which is equivalent to 412 000 deaths annually. Respective fractions were 28·7% (15·5-39·5) for cardiovascular disease mortality and 37·4% (23·4-48·6) for ischaemic heart disease mortality, which correspond to 256 000 deaths a year from cardiovascular disease and 185 000 deaths a year from ischaemic heart disease. Interpretation: Low-level environmental lead exposure is an important, but largely overlooked, risk factor for cardiovascular disease mortality in the USA. A comprehensive strategy to prevent deaths from cardiovascular disease should include efforts to reduce lead exposure. Funding: The Artemis Fund and Simon Fraser University.

Health Impacts Associated with the Implementation of a National Petrol-Lead Phase-out Program (PLPOP): Evidence from Taiwan Between 1981 and 2007.

Transition of Cooking Fuel Types and Mortality Risk in China, 1991-2015.

Blood lead (Pb) is associated with lung fibrotic changes in non-smokers living in the vicinity of petrochemical complex: a population-based study

The Relationship Between Dental Caries and Unleaded Gasoline Usage among Children

The impacts of reduction in ambient fine particulate air pollution on natural-cause mortality in Taiwan

Blood Lead Levels And Their Associated Risk Factors In Chinese Adults From 1980 To 2018

Associations between long-term ambient PM2.5 exposure and the incidence of cardiopulmonary diseases and diabetes, attributable years lived with disability, and policy implication

Public and occupational health risks related to lead exposure updated according to present-day blood lead levels

Analysis of disease profile, and medical burden by lead exposure from hospital information systems in China

Low-level lead exposure and mortality in US adults: a population-based cohort study

Effect of Lead Pollution Control on Environmental and Childhood Blood Lead Level in Nantong, China: an Interventional Study.

Blood Lead Levels among Chinese Children: the Shifting Influence of Industry, Traffic, and E-Waste over Three Decades

The joint effect of long-term exposure to multiple air pollutants on non-accidental and cause-specific mortality: A longitudinal cohort study

Estimating lead-attributable mortality burden by socioeconomic status in the USA

Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan

Health Impact of China's Air Pollution Prevention and Control Action Plan: an Analysis of National Air Quality Monitoring and Mortality Data.

S-23-5: TWO-YEAR RESPONSES OF OFFICE AND AMBULATORY BLOOD PRESSURE TO FIRST OCCUPATIONAL LEAD EXPOSURE

Long-Term Exposures to Air Pollutants and Risk of Peripheral Arterial Occlusive Disease: A Nationwide Cohort Study in Taiwan

Burden of cardiovascular disease attributable to lead exposure in China: a comprehensive analysis of data from 1990 to 2019

Mortality Effects Assessment of Ambient PM2.5 Pollution in the 74 Leading Cities of China.

Traffic Air Pollution and Risk of Death from Breast Cancer in Taiwan: Fine Particulate Matter (pm2.5) As A Proxy Marker